From HIV protein sequences to viral fitness landscapes: a Please share

advertisement

From HIV protein sequences to viral fitness landscapes: a new paradigm for in silico vaccine design

The MIT Faculty has made this article openly available.

Please share

how this access benefits you. Your story matters.

Citation

As Published

Publisher

Version

Accessed

Citable Link

Terms of Use

Detailed Terms

Ferguson, Al, and Arup K. Chakraborty. “From HIV Protein

Sequences to Viral Fitness Landscapes: a New Paradigm for in

Silico Vaccine Design.” Retrovirology 9.Suppl 2 (2012): P331.

http://dx.doi.org/10.1186/1742-4690-9-s2-p331

Biomed Central Ltd.

Final published version

Thu May 26 20:18:37 EDT 2016 http://hdl.handle.net/1721.1/76629

Creative Commons Attribution http://creativecommons.org/licenses/by/2.0

Ferguson and Chakraborty

Retrovirology

2012, 9 (Suppl 2):P331 http://www.retrovirology.com/content/9/S2/P331

P O S T E R P R E S E N T A T I O N Open Access

From HIV protein sequences to viral fitness landscapes: a new paradigm for in silico vaccine design

AL Ferguson

1*

, AK Chakraborty

2

From

AIDS Vaccine 2012

Boston, MA, USA. 9-12 September 2012

Background

An inexpensive prophylactic vaccine offers the best hope to curb the HIV/AIDS epidemic gripping sub-Saharan

Africa. Systematic means to guide the design of an effective immunogen for this, and other, infectious diseases are not available. What is required is a method to chart the peaks and valleys of viral fitness as a function of amino acid sequence. An efficacious vaccine would eject the virus from the high fitness peaks, and drive it into the valleys where its compromised fitness impairs its ability to replicate and inflict damage to the host.

Conclusion

We present a novel methodology to translate viral sequence data into quantitative landscapes of viral fitness.

In an application to HIV-1 Gag, we illustrate excellent agreement of our model predictions with experimental and clinical data, and demonstrate a powerful new approach for HIV immunogen design. We anticipate that this approach may represent a heretofore unprecedented means to synthesize fitness landscapes for diverse pathogens, and may provide the basis for the design of improved prophylactic and therapeutic strategies.

Methods

Appealing to spin glass models in statistical physics, we present a novel approach to translate viral sequence databases into landscapes of viral fitness. These inferred models furnish a quantitative description of viral replicative capacity as a function of amino acid sequence. We illustrate this approach in the development of landscapes for the proteins of HIV-1 clade B Gag.

Results

In comparisons to experimental and clinical data, our inferred landscapes demonstrate excellent agreement with:

1) in vitro replicative fitness measurements, 2) clinically observed high-fitness circulating viral strains, 3) documented HLA associated CTL escape mutations, and 4) intrahost temporal adaptation pathways revealed by deep sequencing. These favorable comparisons support our landscapes as reflections of intrinsic viral fitness. We illustrate the value of such descriptions in the computational design of a CTL Gag immunogen.

Author details

1

University of Illinois at Urbana-Champaign, Urbana, IL, USA.

Cambridge, MA, USA.

2

MIT,

Published: 13 September 2012 doi:10.1186/1742-4690-9-S2-P331

Cite this article as: Ferguson and Chakraborty: From HIV protein sequences to viral fitness landscapes: a new paradigm for in silico vaccine design.

Retrovirology

2012 9 (Suppl 2):P331.

Submit your next manuscript to BioMed Central and take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

1

University of Illinois at Urbana-Champaign, Urbana, IL, USA

Full list of author information is available at the end of the article

Submit your manuscript at www.biomedcentral.com/submit

© 2012 Ferguson and Chakraborty; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the

Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download